People: Atara Biotherapeutics Inc (ATRA.OQ)
25 Apr 2019
Mr. Eric L. Dobmeier is an Independent Director of the Company. He has served as the Chief Operating Officer of Seattle Genetics, Inc., a biotechnology company, since June 2011. Mr. Dobmeier joined Seattle Genetics in March 2002 and has served in positions of increasing responsibility since then. Prior to joining Seattle Genetics, Mr. Dobmeier was an attorney with the law firms of Venture Law Group and Heller Ehrman LLP, where he represented technology companies in connection with public and private financings, mergers and acquisitions and corporate partnering transactions. Mr. Dobmeier also serves as a director of Stemline Therapeutics, Inc., a public biotechnology company. Mr. Dobmeier received a J.D. from the University of California, Berkeley School of Law and an A.B. in History from Princeton University.
|Total Annual Compensation, USD||57,500|
|Restricted Stock Award, USD||96,150|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||176,789|
|Fiscal Year Total, USD||330,439|